siRNA, Anti-NRF1, LNA-modified(CAT#: SIRGT19107WQ-LNA)

The product SIRGT19107WQ-LNA is a type of small interfering RNA (siRNA) that targets NRF1 gene and regulates the expression of gene. The siRNA interferes with the expression of NRF1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001040110.1; NM_001293163.1; NM_001293164.1; NM_005011.4
Alternative Names ALPHA-PAL
Related Diseases Skin Carcinoma In Situ, Oncocytoma
Purification HPLC
Target Gene
Gene ID 4899
Uniprot ID Q16656

Related Products